The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Tresckow, B.
Right arrow Articles by Hansen, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Tresckow, B.
Right arrow Articles by Hansen, H. P.
The Journal of Immunology, 2004, 172: 4324-4331.
Copyright © 2004 by The American Association of Immunologists

Depletion of Cellular Cholesterol and Lipid Rafts Increases Shedding of CD301

Bastian von Tresckow*, Karl-Josef Kallen{dagger}, Elke Pogge von Strandmann*, Peter Borchmann*, Hans Lange{dagger}, Andreas Engert* and Hinrich P. Hansen2,*

* Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany; and {dagger} Department of Biochemistry, University of Kiel, Kiel, Germany

CD30, a lymphoid activation marker, is shed into the cell environment after endoproteolytic cleavage of its ectodomain. Soluble (s)CD30 is able to suppress the Th1-type immune response. Because high serum levels of sCD30 and cholesterol-lowering drugs seem to be beneficial in some Th1-type autoimmune diseases, we focused on a link between CD30 shedding and the amount of cellular cholesterol. Cholesterol depletion of human Hodgkin lymphoma- and non-Hodgkin lymphoma-derived cell lines by methyl-{beta}-cyclodextrin led to a down-regulation of membrane-bound CD30 and increased release of sCD30. Additionally, the cholesterol-interfering drugs lovastatin, cholesterol oxidase, and filipin increased CD30 shedding. Both the down-regulation of membrane-anchored CD30 and the release of sCD30 were dependent on metalloproteinases. Using specific inhibitors, we detected TNF-{alpha} converting enzyme (TACE) as the leading enzyme responsible for cholesterol-dependent CD30 shedding. A Triton X-100-based method for lipid raft isolation revealed that CD30 was partially present in lipid rafts, whereas TACE was localized in the nonraft fractions. Disintegration of lipid rafts by cholesterol depletion might therefore lead to dynamic interactions of CD30 with TACE, resulting in enhanced shedding of CD30. Our results suggest a possible role of cholesterol-dependent shedding of CD30 in the pathogenesis of immune diseases.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Dierker, R. Dreier, A. Petersen, C. Bordych, and K. Grobe
Heparan Sulfate-modulated, Metalloprotease-mediated Sonic Hedgehog Release from Producing Cells
J. Biol. Chem., March 20, 2009; 284(12): 8013 - 8022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Levine
Molecular Mechanisms of Soluble Cytokine Receptor Generation
J. Biol. Chem., May 23, 2008; 283(21): 14177 - 14181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Flanagan, Z. Modrusan, J. Cornelius, A. Chavali, I. Kasman, L. Komuves, L. Mo, and L. Diehl
Intestinal Epithelial Cell Up-Regulation of LY6 Molecules during Colitis Results in Enhanced Chemokine Secretion
J. Immunol., March 15, 2008; 180(6): 3874 - 3881.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
C. Yao, J. E. Donelson, and M. E. Wilson
Internal and Surface-Localized Major Surface Proteases of Leishmania spp. and Their Differential Release from Promastigotes
Eukaryot. Cell, October 1, 2007; 6(10): 1905 - 1912.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Veit, E. P. Zimina, C.-W. Franzke, S. Kutsch, U. Siebolds, M. K. Gordon, L. Bruckner-Tuderman, and M. Koch
Shedding of Collagen XXIII Is Mediated by Furin and Depends on the Plasma Membrane Microenvironment
J. Biol. Chem., September 14, 2007; 282(37): 27424 - 27435.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. A. Eichenauer, V. L. Simhadri, E. P. von Strandmann, A. Ludwig, V. Matthews, K. S. Reiners, B. von Tresckow, P. Saftig, S. Rose-John, A. Engert, et al.
ADAM10 Inhibition of Human CD30 Shedding Increases Specificity of Targeted Immunotherapy In vitro
Cancer Res., January 1, 2007; 67(1): 332 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Vaisanen, M.-R. Vaisanen, and T. Pihlajaniemi
Modulation of the Cellular Cholesterol Level Affects Shedding of the Type XIII Collagen Ectodomain
J. Biol. Chem., November 3, 2006; 281(44): 33352 - 33362.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Kay, R. Z. Murray, J. K. Pagan, and J. L. Stow
Cytokine Secretion via Cholesterol-rich Lipid Raft-associated SNAREs at the Phagocytic Cup
J. Biol. Chem., April 28, 2006; 281(17): 11949 - 11954.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
W. A. Shah, H. Peng, and S. Carbonetto
Role of non-raft cholesterol in lymphocytic choriomeningitis virus infection via {alpha}-dystroglycan.
J. Gen. Virol., March 1, 2006; 87(Pt 3): 673 - 678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. P. Zimina, L. Bruckner-Tuderman, and C.-W. Franzke
Shedding of Collagen XVII Ectodomain Depends on Plasma Membrane Microenvironment
J. Biol. Chem., October 7, 2005; 280(40): 34019 - 34024.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Chakraborty, S. Banerjee, A. Sen, K. K. Banerjee, P. Das, and S. Roy
Leishmania donovani Affects Antigen Presentation of Macrophage by Disrupting Lipid Rafts
J. Immunol., September 1, 2005; 175(5): 3214 - 3224.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Gutwein, A. Stoeck, S. Riedle, D. Gast, S. Runz, T. P. Condon, A. Marme, M.-C. Phong, O. Linderkamp, A. Skorokhod, et al.
Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells
Clin. Cancer Res., April 1, 2005; 11(7): 2492 - 2501.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Levine
Mechanisms of Soluble Cytokine Receptor Generation
J. Immunol., November 1, 2004; 173(9): 5343 - 5348.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.